LDE225 + Docetaxel/Prednisone for Adv/Met Castrate Resistant Prostate Cancer w/ Disease Progression After Docetaxel

Clinical trial NCT02182622 · WITHDRAWN

Trial details

NCT number: NCT02182622
Sponsor: Martin Gutierrez
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2014-07-01
Primary completion: 2015-12-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.